Sort
39,280 grants matching “leukemia”
Safe and Efficient Generation of hES-derived Bone Marrow
$371,684Margaret Goodell · Baylor College Of Medicine · R01 · FY2008 · DK
Elucidating the AKT-dependent and AKT-independent mechanisms of metabolic control by mTORC2
$371,660David A Guertin · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · CA
NEW SYNTHETIC METHODS FOR DIVERSE SMALL MOLECULE LIBRARY PREPARATION
$371,640Donald Watson · University Of Delaware · P20 · FY2014 · GM
Molecular Genetic Changes in Leukemia in Infants
$371,634Children'S Hospital Of Philadelphia · R01 · FY2003 · CA
Role of cross-presentation by APCs in modulating graft-versus-leukemia responses
$371,626Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2012 · HL
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients
$371,600Craig A Elmets · University Of Alabama At Birmingham · P01 · FY2019 · CA
Deep Proteomic Profiling of Rare Cells
$371,593Alexander R. Ivanov · Northeastern University · R01 · FY2016 · GM
Leukemogenesis by Murine Retroviruses
$371,575Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2005 · CA
Leukemogenesis by Murine Retroviruses
$371,575Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2004 · CA
Leukemogenesis by Murine Retroviruses
$371,575Yeshiva University · R01 · FY2003 · CA
Roles of EAF2 in androgen action in the prostate
$371,525Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Roles of EAF2 in androgen action in the prostate
$371,525Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
Roles of EAF2 in androgen action in the prostate
$371,525Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
Roles of EAF2 in androgen action in the prostate
$371,525Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
Nonmyeloablative Hematopoietic Cell Allotransplants
$371,499Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA
Mechanism of Antibody Neutralization of Viruses
$371,481Xinzhen Yang · Beth Israel Deaconess Medical Center · R01 · FY2010 · AI
Targeting cytoplasmic SET oncoprotein by sphingolipid analog drugs for the induction of necroptosis to treat lung cancer
$371,477Besim Ogretmen · Medical University Of South Carolina · R01 · FY2025 · CA
DNA Adducts of Styrene and Other Vinyl Monomers
$371,450Michael P Stone · Vanderbilt University · R01 · FY2009 · ES
DNA Adducts of Styrene and Other Vinyl Monomers
$371,450Michael P Stone · Vanderbilt University · R01 · FY2008 · ES
Biomarkers of Formaldehyde Exposure and Toxicity
$371,446Luoping Zhang · University Of California Berkeley · R01 · FY2010 · ES
Molecular Chimerism Therapy for Hemophilia A
$371,408Robert G. Hawley · George Washington University · R01 · FY2009 · HL
Molecular Chimerism Therapy for Hemophilia A
$371,408Robert G. Hawley · George Washington University · R01 · FY2008 · HL
Molecular Chimerism Therapy for Hemophilia A
$371,408Robert G. Hawley · George Washington University · R01 · FY2007 · HL
PLM, PLZF, NPM and NuMA in the Molecular Pathogenesis of APL
$371,378Pier Paolo Pandolfi · Sloan-Kettering Inst Can Research · R37 · FY2006 · CA
Bone Marrow Spatial Transcriptomics to Enhance In Vitro Platelet Production
$371,377Alan B. Cantor · Boston Children'S Hospital · R01 · FY2021 · HL